West Nile virus (WNV), and related flaviviruses such as tick-borne encephalitis, Japanese encephalitis, yellow fever and dengue viruses, constitute a significant global human health problem 1 . However, our understanding of the molecular interaction of such flaviviruses with mammalian host cells is limited 1 . WNV encodes only 10 proteins, implying that it may use many cellular proteins for infection 1 . WNV enters the cytoplasm through pH-dependent endocytosis, undergoes cycles of translation and replication, assembles progeny virions in association with endoplasmic reticulum, and exits along the secretory pathway [1] [2] [3] . RNA interference (RNAi) presents a powerful forward genetics approach to dissect virus-host cell interactions 4-6 . Here we report the identification of 305 host proteins that affect WNV infection, using a human-genome-wide RNAi screen. Functional clustering of the genes revealed a complex dependence of this virus on host cell physiology, requiring a wide variety of molecules and cellular pathways for successful infection. We further demonstrate a requirement for the ubiquitin ligase CBLL1 in WNV internalization, a post-entry role for the endoplasmic-reticulum-associated degradation pathway in viral infection, and the monocarboxylic acid transporter MCT4 as a viral replication resistance factor. By extending this study to dengue virus, we show that flaviviruses have both overlapping and unique interaction strategies with host cells. This study provides a comprehensive molecular portrait of WNV-human cell interactions that forms a model for understanding single plus-stranded RNA virus infection, and reveals potential antiviral targets.
West Nile virus (WNV), and related flaviviruses such as tick-borne encephalitis, Japanese encephalitis, yellow fever and dengue viruses, constitute a significant global human health problem 1 . However, our understanding of the molecular interaction of such flaviviruses with mammalian host cells is limited 1 . WNV encodes only 10 proteins, implying that it may use many cellular proteins for infection 1 . WNV enters the cytoplasm through pH-dependent endocytosis, undergoes cycles of translation and replication, assembles progeny virions in association with endoplasmic reticulum, and exits along the secretory pathway [1] [2] [3] . RNA interference (RNAi) presents a powerful forward genetics approach to dissect virus-host cell interactions [4] [5] [6] . Here we report the identification of 305 host proteins that affect WNV infection, using a human-genome-wide RNAi screen. Functional clustering of the genes revealed a complex dependence of this virus on host cell physiology, requiring a wide variety of molecules and cellular pathways for successful infection. We further demonstrate a requirement for the ubiquitin ligase CBLL1 in WNV internalization, a post-entry role for the endoplasmic-reticulum-associated degradation pathway in viral infection, and the monocarboxylic acid transporter MCT4 as a viral replication resistance factor. By extending this study to dengue virus, we show that flaviviruses have both overlapping and unique interaction strategies with host cells. This study provides a comprehensive molecular portrait of WNV-human cell interactions that forms a model for understanding single plus-stranded RNA virus infection, and reveals potential antiviral targets.
The host proteins previously reported to facilitate WNV infection (termed host susceptibility factors, HSFs) comprise endosomal transport regulators and vATPase (for entry), eEF1A, TIA-1/TIAR and HMGCR (for replication), and c-Yes (for secretion) 2, 3, [7] [8] [9] [10] . Other host proteins may reduce WNV infection (termed host resistance factors, HRFs): components of the antiviral IRF3 pathway are known HRFs of WNV infection 11 . In this context, we performed a genomescale small interfering RNA (siRNA)-based screen silencing 21, 121 human genes in HeLa cells to comprehensively identify the cellular proteins associated with the early stages of WNV infection, from viral entry through to the intracellular translation of viral RNA. Defects in the later stages of infection, such as replication, assembly or secretion, were not scored by the assay. The assay involved infection of genesilenced cells with WNV for 24 h, followed by a microscopy-based quantification of the cells immunostained for viral envelope protein to select the candidate host proteins. The screen was done in two steps: a primary screen using a pool of four siRNAs per gene, followed by a validation screen, testing each individual siRNA within the pool separately (for the hits selected in the primary screen) to minimize potential off-target hits (Fig. 1a) . The details of the assay and screen are described in Methods and Supplementary Fig. 1 .
The RNAi screen identified 283 HSFs and 22 HRFs (of which 273 and 21 respectively are novel; Supplementary Tables 1 and 2 ). The number of HRFs constituted 7% of the total host factors identified. The identification of (1) some of the known HSFs (vATPase, endosomal transport regulators 3 ) and HRFs (IRF3; ref. 11) of WNV infection, and (2) multiple components of macromolecular assemblies-for example, vATPase, the endoplasmic-reticulum-associated degradation (ERAD) pathway, focal adhesion complex (FAC)-validated the reliability of our approach and the in vitro model. A cellular map summarizing several screen hits classified into cellular compartments and broad functional association categories is provided in Supplementary Fig. 2 .
Of the 283 HSFs, 195 (69%) and 193 (68%) could be classified using biological process and molecular function categories, respectively ( Fig. 1b, c ; Supplementary Tables 3 and 4 ). There was a significant enrichment of genes regulating intracellular protein trafficking, cell adhesion and processes associated with the transport of ions and biomolecules. The enriched molecular function categories included hydrolases, transporters, ligases, cell adhesion molecules, membrane traffic proteins and synthases. Among the HSFs, 6 RNA-binding proteins (for example, RBPMS), 20 ubiquitination-related proteins (for example, CBLL1), 21 transcription factors (for example, LDB1), 3 C-type lectins (CLEC7A, CLEC4A and CLEC4C) and 5 protocadherins (for example, PCDHB5) were also present. The RNA-binding protein RBPMS was reported as part of a protein network implicated in Purkinje cell degeneration 12 . Strikingly, the current screen also captured seven other members (COIL, PCP4, UBE2I, LDB1, NUMBL, ATXN7L3 and USP6) interacting with RBPMS (Supplementary Figs 3a, b, and 4a, b) .
The screen also identified several genes previously implicated in immunity (Supplementary Tables 1 and 2 ). Immune related HSFs include b-defensins (DEFB118 and DEFB129, Supplementary Fig.  5a ), Rnase L inhibitor ABCE1 (refs 13-15; Supplementary Fig. 5b ), LY6E, Zap70, TNFSF13B and DUBA (OTUD5). Among the HRFs, a-defensin DEFA3 and IRF3 are known immune response genes. These findings highlight that defensin family members function as both viral resistance and susceptibility factors 16 . Knockdown of the immunophilin FKBP1B also enhanced WNV infection.
We next determined whether the genes identified from HeLa cells are expressed in tissues targeted by WNV in vivo by analysing the expression pattern of the HSFs across 79 tissues ( Supplementary Fig.  6 ). In accordance with the tissue tropism of WNV, 102 (46%) and 64 (29%) HSFs showed enriched expression in immune and central nervous system tissues, respectively (Wilcoxon P , 0.05; Supplementary Tables 5 and 6 ).
Among the 20 ubiquitination-related proteins identified in the screen, the ubiquitin ligase CBLL1 is known to regulate the endocytosis of cell-surface receptors, and therefore we hypothesized that CBLL1 may be involved in the cellular internalization of WNV 17 . CBLL1 silencing resulted in a marked reduction (82%, P 5 0.05) of WNV-infected cells ( Fig. 2a, b; Supplementary Figs 4a, b, and 7a) . In order to test whether CBLL1 is involved in WNV entry, we next examined the kinetics of tetramethyl rhodamine iso-thiocyanate (TRITC)-labelled WNV particle internalization into CBLL1 silenced cells. Strikingly, there was a ,20-fold (P , 0.05) reduction in the number of virus particles present within CBLL1 silenced cells when analysed from 1 h to 4 h post-incubation ( Fig. 2c; Supplementary Fig.  7b ). Moreover, virus was seen stuck on the plasma membrane of 17% of CBLL1 silenced cells ( Fig. 2d; Supplementary Figs 7b and 8 ). As expected, CBLL1 silencing did not alter WNV replicon translation ( Supplementary Fig. 9a ). The virus internalization defect of CBLL1 silenced cells was similar to that observed in cells defective for clathrin dependent endocytosis (CDE), a pathway implicated in WNV entry ( Fig. 2d) 2,3 . CDE was ablated by targeting the clathrin adaptor AP3S2, which was also identified in our screen (Supplementary Table  1) 18 . Silencing of the post-entry HSF, vATPase, did not alter the internalization of virus (Fig. 2d) . Furthermore, consistent with the involvement of a ubiquitin ligase in WNV entry, depletion of cellular free ubiquitin pool by pretreatment with MG132 (a proteasomal inhibitor) strongly abolished WNV internalization (50-fold, P 5 0.001) ( Fig. 2e; Supplementary Fig. 4b ). Notably, proteasome inhibition was also found to interfere with WNV infection at postinternalization steps ( Supplementary Fig. 9b ). Proteasomal components were also identified in the screen (Supplementary Table 1) . Demonstrating WNV specificity, MG132 treatment did not inhibit vesicular stomatitis virus infection ( Supplementary Fig. 9c ), as reported previously 19 .
Collectively, these findings demonstrate that CBLL1 and the proteasome-ubiquitin system are required for the cellular internalization of WNV.
Because the endoplasmic reticulum (ER) is implicated in the intracellular phase of flaviviral life cycle 1 , we examined whether WNV co-opts ER components for infection. Network analysis anchoring on ER proteins revealed the presence of several components of the ERAD pathway among the identified HSFs (Fig. 2f) . ERAD comprises Gene silenced LETTERS more than ten proteins that retro-transports misfolded proteins from ER to the proteasome 20 . Silencing of several key components or interactors of ERAD (HRD1, DERL2, UBE2J1/UBC6, UBE3A, SEC61G, SEC61A1, UFD1L and NSFL1C), but not other ERAD components (for example, DERL1, DERL3, HRD3, NPL4 and p97), reduced WNV infected cells up to 89% ( Fig. 2g; Supplementary Fig. 4a, b) . ERAD was not required for human immunodeficiency virus 2 infection ( Supplementary Fig. 10a) , highlighting specificity between different viruses. To further validate these results, reduction of viral infection due to silencing of DERL2 was rescued by transfection with an siRNAresistant silent mutation-containing variant of DERL2 ( Fig. 2g;  Supplementary Fig. 10b ). We also identified the recently reported ERAD component BCAP31 as an HSF 21 . Functional studies revealed that ERAD is not involved in WNV internalization, endosomal transport 2 , or RNA translation; however, there was ,10% reduction in the secretion of progeny virions in ERAD silenced cells ( Supplementary  Fig. 11a-d, respectively) . Interestingly, the simian virus 40 has been shown recently to require the ERAD components DERL1 and SEL1L for uncoating 22 . Together, these results indicate that WNV infection requires a subset of ERAD components at a post-internalization step.
Among the genes whose knockdown enhanced WNV infection, the strongest phenotype was observed when MCT4 (SLC16A4), a plasma membrane transporter of monocarboxylic acids 23 , was silenced. Three of the four tested siRNAs targeting MCT4 resulted in a 10-fold (P 5 0.01) increase in WNV infected cells at 24 h (Fig. 3a,  b ; Supplementary Fig. 4a, b) . A quantitative PCR-based time-course analysis of the viral genomic RNA (plus-strand) revealed a similar rate of WNV particle internalization into both MCT4-repressed and control cells (Fig. 3c) . However, replication started at #9 h post infection in MCT4-silenced cells, whereas in control cells it was delayed until after 12 h (Fig. 3c) . Consistent with this, MCT4 silenced cells (1) had 3, 10, 12 and 18 times (P , 0.05) more viral plus-strand RNA at 9 h, 12 h, 15 h and 24 h post infection, respectively (Fig. 3c) ; (2) immuno-stained for WNV antigens at 9 h (not detectable in control cells until after 12 h; Fig. 3d ), and (3) secreted progeny virions by 12 h, whereas control cells did not (Fig. 3e) . However, importantly, replication of viral genomic RNA introduced directly to the cytoplasm bypassing the entry stages was not affected by MCT4 silencing ( Supplementary Fig. 12 ). Collectively, these observations show that the functional activity of MCT4 delays the temporal transition into the replication phase of endocytosed WNV particles.
We next examined whether the host cell interaction strategies are similar between different members of the genus Flavivirus by investigating the effect of silencing all the identified WNV HSFs and HRFs in Fig. 1a, b) . Silencing of 36% of the WNV HSFs reduced DENV infection, including previously implicated vATPase and UBE2I (Supplementary Table 1 ) 3, 24 . In contrast, all the 22 WNV HRFs increased DENV infection (Supplementary Table 2 ). Further supporting pathogen specificity, only five of the host factors impacting WNV infection altered HIV-2 infection (not shown). 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 An assessment of enrichment for biological process categories revealed significant over-representation (P , 0.05) of seven key processes in which HSFs are targeted by both WNV and DENV (Fig. 4a) , relative to their representation among all HSFs identified. We selected three pathways-ERAD, FAC and histone deacetylase (HDAC)-to compare the conservation between WNV and DENV. There was a near-complete overlap of ERAD component usage shared by both WNV and DENV, with the single exception of HRD1 (Supplementary Fig. 13a) . Silencing of 4 genes constituting the FAC core (for example, PXN, SHC1, PITPNM2 and PTK2B), and 33 interactors, reduced WNV infection (Fig. 4b, c; Supplementary  Fig. 4a, b ) 25 . Reduction of WNV infection in PITPNM2 silenced cells was also rescued with an siRNA resistant PITPNM2 mutant (Supplementary Fig. 13b) . Notably, only one core FAC component (PITPNM2) and 11 interactors reduced DENV infection (Fig. 4b, c) . Among the nine HDAC components associated with WNV infection, four were required for DENV (Supplementary Fig. 13c ). These examples indicate that WNV and DENV may have evolved different sensitivities in their interaction with host proteins, and this may be reflected in the differences in their biology.
HeLa cells infected by dengue virus 2 (DENV). We determined that 30 h post-infection of DENV is comparable to the 24 h infection of WNV (Supplementary
In summary, this study portrays a comprehensive genome-scale map of human proteins and cellular pathways affecting the outcome of flavivirus-host cell interactions, and presents a potentially useful resource for further studies. Furthermore, these results may provide insights into the molecular differences in the pathogenesis of related flaviviruses, and reveal potential flaviviral therapeutic targets.
METHODS SUMMARY
RNAi screen. Any gene for which a minimum of two siRNAs reduced (HSF) or increased (HRF) the percentage of infected cells by $2-fold, and the fold change was $2 times the standard deviation (s.d.) of the percentage of control cells infected, was scored as a hit. Gene silencing that resulted in a cell number decrease $2 times the s.d. (of controls) was considered toxic and excluded. Immunofluorescence assay sensitivity determination. As positive controls to determine whether the immunofluorescence assay (IFA) can detect changes in viral replication, the previously reported WNV replication impacting host gene HMGCR was silenced ( Supplementary Fig. 1c, d) ; and to test whether IFA can detect changes in viral translation, host translation machinery was arrested by cycloheximide ( Supplementary Fig. 1e ). Anti-WNV siRNA was also used as a positive control (Supplementary Table 9 ). Results showed that the IFA was sensitive enough to detect changes in viral RNA translation, but not later stages such as replication. Bioinformatic analysis. Genes were categorized using the PANTHER classification system 26 . Enrichment was analysed using the hypergeometric probability distribution. For tissue expression analysis, microarray data files were obtained from the Novartis GNF human expression atlas version 2 resource 27 . The protein network constructions used interaction data from the Human Protein Reference Database (HPRD) 28 , the Biomolecular Interaction Network Database (BIND) 29 and the Ingenuity pathways database (Mountainview, CA), supplemented with functional information from the literature.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. , and imaged by fluorescence microscopy (Molecular Devices, 43 magnification) using a TRITC filter for virus and DAPI filter for nuclei. Infection was done at an m.o.i. of 0.3 for both WNV and DENV. Generally, infection was in the range of 20-30% for both WNV and DENV. As positive control of infection reduction due to gene silencing, endosomal proton pump vATPase was silenced. Cell number per well was in the range 7,000-9,000. The percentage infection was relatively linear in the cell number range in which the screen was performed (Supplementary Fig. 1f ). Each 384-well plate had additional control wells with a non-targeting control siRNA (siCONTROL non-targeting siRNA, Dharmacon) (for determining the general effect of siRNA transfection on infection), siRNA targeting PLK-1 whose silencing kills the cells (for determining general knockdown efficiency), fluorescently labelled non-targeting control siRNA (for determining transfection efficiency), and wells with neither transfection reagent nor siRNA. Quantification of the effect of gene silencing on viral infection was done using the software Metamorph (Molecular Devices), which counted cells that were immuno-stained versus non-stained for virus antigen. Based on the infection kinetics and infection inhibition by the silencing of a host gene known to be required for the infection of both WNV and DENV (vATPase, Supplementary Fig. 1b) , we defined an infection reduction of twofold or greater at 24 h for WNV or 30 h for DENV as the threshold for hit selection. Silencing of vATPase resulted in a reduction of infection of 2.9 6 0.3 fold compared to the controls for WNV or 2.7 6 0.4 for DENV ( Supplementary Fig. 1b) . Cell lines and virus propagation. Gene silencing and infection studies were done on low passage HeLa (ATCC no. CCL-2.1) cells maintained in DMEM supplemented with 10% fetal bovine serum. West Nile virus (strain 2471, gift of J. Anderson), and dengue 2 virus (New Guinea C strain, gift of A. de Silva) viruses were grown on vero (ATCC no. CRL-1586) or C6/36 (ATCC no. CRL-1660) cells, respectively. Gene knockdown verification, RNAi resistant mutant generation and phenotype rescue. For the quantitation of the target transcript reduction, pooled siRNAs corresponding to the tested genes were transfected (50 nM) to cells (or cells pre-transfected with cDNAs of genes) in 48-well plates for 3 days, total RNA was isolated using the RNeasy kit (Qiagen), and cDNA was prepared using the iScript kit (Biorad). Quantitative PCR (qPCR) was performed by using Sybergreen reagent (Biorad). The primers used were given in the Supplementary Table 7 . To generate RNAi resistant variants of genes, four silent mutations each was introduced into those sequences of DERL2 and PITPNM2 where siRNA binds (in the expression vector pCDNA6.2 with V5 tag), using QuickChange Mutagenesis kit (Strategene) (Supplementary Table 7 shows the mutagenesis primer sequences). HeLa cells transfected separately with wild type or mutant copies of the genes were selected for 8 days using blasticidin, treated with siRNA for 72 h, and either WNV infection assay or western blot (for knock down and rescue verification) was performed. Six random fields of fluorescent images (103 objective, Zeiss Axiovert 200M) of WNV infected mutant versus wild type gene expressing cells were counted to quantify and assess the rescue of viral infection by mutant genes. For western blot, cells were lysed in 1% 50 mM Tris-HCL, 150 mM NaCl and Triton X-100. Western blot was performed to verify the extent of knockdown and rescue of DERL2 and PITPNM2 using anti-V5 antibodies (Invitrogen). Anti-CBLL1 antibody was obtained from Abcam.
Cytotoxicity. Cytotoxic effects of gene silencing and MG132 treatments were determined using LDH release assay kit (Roche). Supernatants of gene silenced cells were harvested at 3 days post-transfection or 1-24 h post treatment for compounds, and assayed for LDH release according to manufacturer's protocol. Viral RNA transfection and secretion studies. Two kinds of studies were done using viral genomic RNA transfection: (1) determination of the effect of gene silencing on viral RNA translation, and (2) determination of the effect of gene silencing on progeny virion secretion. The RNA of a subgenomic replicon of WNV (lacking complete genes for the capsid, pre-membrane, and envelope proteins) was used for viral translation studies 30 , while a full length viral genome was used for viral secretion studies 31 . The viral RNA was prepared as described previously 31 . The viral RNA was transiently transfected into HeLa cells by electroporation, after gene knock down with siRNA for 3 days. Mouse hyperimmune ascitic fluid against WNV was used for the immunofluorescence of replicon transfected cells, after 14 h of transfection. For the viral secretion assay, the culture supernatants were collected at 24 h from HeLa cells electroporated with (400 ng) full length WNV genomic RNA for ERAD silenced cells. As positive control for inhibition of WNV secretion, brefeldin A (10 mg ml
